A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study) (2016)
- Authors:
- Autor USP: MANO, MAX SENNA - FM
- Unidade: FM
- DOI: 10.1016/j.clbc.2015.10.005
- Subjects: SEGUIMENTOS; NEOPLASIAS MAMÁRIAS; METÁSTASE NEOPLÁSICA; ANTINEOPLÁSICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical Breast Cancer
- ISSN: 1526-8209
- Volume/Número/Paginação/Ano: v. 16, n. 1, p. 38-44, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
GÓMEZ, Henry L. et al. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study). Clinical Breast Cancer, v. 16, n. 1, p. 38-44, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.clbc.2015.10.005. Acesso em: 13 nov. 2024. -
APA
Gómez, H. L., Neciosup, S., Tosello, C., Mano, M., Bines, J., Ismael, G., et al. (2016). A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study). Clinical Breast Cancer, 16( 1), 38-44. doi:10.1016/j.clbc.2015.10.005 -
NLM
Gómez HL, Neciosup S, Tosello C, Mano M, Bines J, Ismael G, Santi PX, Pinczowski H, Nerón Y, Fanelli M, Fein L, Sampaio C, Lerzo G, Capó A, Zarba JJ, Blajman C, Varela MS, Martínez-Mesa J, Werutsky G, Barrios CH. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study) [Internet]. Clinical Breast Cancer. 2016 ; 16( 1): 38-44.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.clbc.2015.10.005 -
Vancouver
Gómez HL, Neciosup S, Tosello C, Mano M, Bines J, Ismael G, Santi PX, Pinczowski H, Nerón Y, Fanelli M, Fein L, Sampaio C, Lerzo G, Capó A, Zarba JJ, Blajman C, Varela MS, Martínez-Mesa J, Werutsky G, Barrios CH. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study) [Internet]. Clinical Breast Cancer. 2016 ; 16( 1): 38-44.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.clbc.2015.10.005 - Value of systemic staging in asymptomatic early breast cancer
- Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
- Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1
- Reply to [Carta]: mastectomy skin flap thickness
- O uso do Oncotype DX® na indicação de quimioterapia adjuvante - experiência do Hospital Sírio-Libanês
- Pneumonite não-infecciosa em paciente com tumor neuroendócrino tratado com everolimus (EVR)
- Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy
- HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials
- Return to work after breast cancer diagnosis: An observational prospective study of 125 patients in South America
- Malignancy-related hypercalcemia in the bishosphonate era
Informações sobre o DOI: 10.1016/j.clbc.2015.10.005 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
